Chinese Herbal Medicine for Symptom Management in Cancer Palliative Care: Systematic Review And Meta-analysis
Vincent C.H. Chung; Xinyin Wu; Ping Lu; Edwin P. Hui; Yan Zhang; Anthony L. Zhang; Alexander Y.L. Lau; Junkai Zhao; Min Fan; Eric T.C. Ziea; Bacon F.L. Ng; Samuel Y.S. Wong; Justin C.Y. Wu
Author Information: From the Hong Kong Institute of Integrative Medicine (VCHC, XW, EPH, AYLL, SYSW, JCYW), The Chinese University of Hong Kong, Hong Kong, China; School of Public Health and Primary Care (VCHC, XW, PL, JZ, MF, SYSW), The Chinese University of Hong Kong, Hong Kong, China; Comprehensive Cancer Trials Unit (EPH), The Chinese University of Hong Kong, Hong Kong, China; Department of Family and Community Medicine (YZ), Texas Tech University, Lubbock; Australian Research Centre in Complementary and Integrative Medicine (ARCCIM), Faculty of Health (YZ, ALZ), University of Technology Sydney, Sydney, Australia; Traditional & Complementary Medicine Research Program (ALZ), School of Health Sciences and Health Innovations Research Institute, RMIT University, Melbourne, Australia; Department of Medicine and Therapeutics (AYLL, JCYW), The Chinese University of Hong Kong, Hong Kong, China; and Chinese Medicine Department (ETCZ, BFLN), Hong Kong Hospital Authority, Hong Kong, China.
Issn Print: 0025-7974
Publication Date: 2016/02/01
|Checking for direct PDF access through Ovid|
Use of Chinese herbal medicines (CHM) in symptom management for cancer palliative care is very common in Chinese populations but clinical evidence on their effectiveness is yet to be synthesized.